{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:46:10Z","timestamp":1793814370304,"version":"4.6.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.forsciint.2019.110101","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T22:28:56Z","timestamp":1576708136000},"page":"110101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Femoral blood concentrations of flualprazolam in 33 postmortem cases"],"prefix":"10.1016","volume":"307","author":[{"given":"Pirkko","family":"Kriikku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilpo","family":"Rasanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla","family":"Thelander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kronstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svante","family":"Vikingsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2019.110101_bib0005","article-title":"Identification and characterization of the new designer benzodiazepines bromazolam, flualprazolam and fluclotizolam","author":"Wilde","year":"2018","journal-title":"Poster at TIAFT Conference in Ghent"},{"key":"10.1016\/j.forsciint.2019.110101_bib0010","series-title":"Handbook of Experimental Pharmacology, New Psychoactive Substances","first-page":"383","article-title":"Designer benzodiazepines: another class of new psychoactive substances","author":"Moosmann","year":"2018"},{"key":"10.1016\/j.forsciint.2019.110101_bib0015","unstructured":"J. B. Hester Jr, U.S. Patent No. 3,987,052. Washington, DC: U.S. Patent and Trademark Office, 1976."},{"key":"10.1016\/j.forsciint.2019.110101_bib0020","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/jm00293a015","article-title":"6-Phenyl-4H-s-triazolo [4, 3-a][1, 4] benzodiazepines which have central nervous system depressant activity","volume":"14","author":"Hester","year":"1971","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.forsciint.2019.110101_bib0025","unstructured":"https:\/\/chat.tripsit.me\/ (Accessed 11th September 2019)."},{"key":"10.1016\/j.forsciint.2019.110101_bib0030","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkz063","article-title":"Validation of an LC-MS\/MS method for the quantification of 13 designer benzodiazepines in blood","author":"Mei","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2019.110101_bib0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/jms.1030","article-title":"Fast gas chromatography-negative-ion chemical ionization mass spectrometry with microscale volume sample preparation for the determination of benzodiazepines and alpha-hydroxy metabolites, zaleplon and zopiclone in whole blood","volume":"41","author":"Gunnar","year":"2006","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2019.110101_bib0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jat\/bkw059","article-title":"Postmortem brain and blood reference concentrations of alprazolam, bromazepam, chlordiazepoxide, diazepam, and their metabolites and a review of the literature","volume":"40","author":"Skov","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2019.110101_bib0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.forsciint.2014.01.005","article-title":"Sedative and hypnotic drugs\u2014fatal and non-fatal reference blood concentrations","volume":"236","author":"J\u00f6nsson","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2019.110101_bib0050","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/dta.2655","article-title":"Summary statistics for drug concentrations in post\u2010mortem femoral blood representing all causes of death","volume":"11","author":"Ketola","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2019.110101_bib0055","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/dta.2146","article-title":"In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples","volume":"9","author":"Noble","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2019.110101_bib0060","unstructured":"https:\/\/energycontrol-international.org\/alert-update-on-adulterated-samples-of-alprazolam\/ (Accessed 11th September)."},{"key":"10.1016\/j.forsciint.2019.110101_bib0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000090430","article-title":"What characterizes substance abusers who commit suicide attempts? Factors related to Axis I disorders and patterns of substance use disorders","volume":"12","author":"Landheim","year":"2006","journal-title":"Eur. Addict. Res."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819305134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073819305134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T17:57:51Z","timestamp":1759946271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073819305134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":13,"alternative-id":["S0379073819305134"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.110101","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Femoral blood concentrations of flualprazolam in 33 postmortem cases","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2019.110101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110101"}}